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Abstract
Background/Objective:  Colorectal  and  gynecologic  cancer  survivors  are  at  cardiovascular  risk
due to  comorbidities  and  sedentary  behaviour,  warranting  a  feasible  intervention  to  increase
physical activity.  The  Health  Action  Process  Approach  (HAPA)  is  a  promising  theoretical  frame-
work for  health  behaviour  change,  and  wearable  physical  activity  trackers  offer  a  novel  means
of self-monitoring  physical  activity  for  cancer  survivors.
Method:  Sixty-eight  survivors  of  colorectal  and  gynecologic  cancer  will  be  randomised  into  12-
week intervention  and  control  groups.  Intervention  group  participants  will  receive:  a  Fitbit
AltaTM to  monitor  physical  activity,  HAPA-based  group  sessions,  booklet,  and  support  phone-
call. Participants  in  the  control  group  will  only  receive  the  HAPA-based  booklet.  Physical  activity
(using accelerometers),  blood  pressure,  BMI,  and  HAPA  constructs  will  be  assessed  at  baseline,
12-weeks  (post-intervention)  and  24-weeks  (follow-up).  Data  analysis  will  use  the  Group  x  Time
interaction  from  a  General  Linear  Mixed  Model  analysis.
∗ Corresponding author. School of Psychology, Curtin University, PO Box U1987, Perth, Western Australia, 6845.
E-mail address: chloe.maxwell-smith@curtin.edu.au (C. Maxwell-Smith).
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusions:  Physical  activity  interventions  that  are  acceptable  and  have  robust  theoretical
underpinnings  show  promise  for  improving  the  health  of  cancer  survivors.
© 2018  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Published  by  Elsevier  Espan˜a,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Pulseras  inteligentes  de  actividad  física  y  plan  de  acción  (WATAAP)  para  promover  la
actividad  física  en  sobrevivientes  de  cáncer:  protocolo  de  un  ensayo  aleatorizado
Resumen
Antecedentes/Objetivo:  Los  sobrevivientes  de  cáncer  tienen  riesgo  cardiovascular  debido  a
la comorbilidad  y  al  comportamiento  sedentario,  lo  que  justiﬁca  desarrollar  una  adecuada
intervención  para  aumentar  la  práctica  de  actividad  física.  El  Enfoque  del  Proceso  de  Acción
de Salud  (EPAS)  constituye  un  marco  teórico  para  el  desarrollo  de  conductas  saludables  y  los
dispositivos electrónicos  de  actividad  física  son  nuevas  herramientas  de  automonitorización
para los  supervivientes  de  cáncer.
Método:  Sesenta  y  ocho  sobrevivientes  de  cáncer  colorrectal  y  ginecológico  serán  aleatorizados
en grupos  de  intervención  y  control.  Los  participantes  del  grupo  de  intervención  recibirán  un
Fitbit AltaTM para  monitorizar  la  actividad  física,  sesiones  grupales  y  aplicación  de  un  folleto
de EPAS,  y  una  llamada  telefónica  de  apoyo.  Los  participantes  del  grupo  control  únicamente
recibirán  un  folleto  basado  en  EPAS.  Al  inicio  del  estudio,  a  las  12  y  24  semanas,  se  evaluarán
la actividad  física  (usando  acelerómetros),  la  presión  arterial,  el  Índice  de  Masa  Corporal  (IMC)
y los  constructos  EPAS.  El  análisis  de  datos  utilizará  la  interacción  Grupo  x  Tiempo  a  partir  de
un análisis  del  Modelo  Mixto  Lineal  General.
Conclusiones:  Las  intervenciones  de  actividad  física  son  factibles  y  tienen  fundamentos  teóricos
que auguran  mejorar  la  salud  de  los  sobrevivientes  de  cáncer.
© 2018  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Cancer  survivors  are  at  increased  risk  of  secondary  can-
cers,  cardiovascular  disease  (CVD)  and  other  comorbidities
compared  to  those  without  a  cancer  history  (Rock  et  al.,
2012).  Despite  cancer  survival  rates  improving,  survivors
of  colorectal  and  gynaecological  cancers  continue  to  be  at
cardiovascular  risk  due  to  their  physical  inactivity.  Up  to
70%  of  endometrial  cancer  survivors  are  obese  (von  Grueni-
gen  et  al.,  2008),  and  these  survivors  are  twice  as  likely
to  die  from  not  meeting  the  government’s  physical  activ-
ity  guidelines  of  150-minutes  of  moderate-intensity  physical
activity  per  week  (Fisher,  Smith,  &  Wardle,  2016).  Fifty-eight
percent  of  colorectal  cancer  survivors  are  overweight  or
obese,  and  83%  are  insufﬁciently  active  (Grimmett,  Bridge-
water,  Steptoe,  &  Wardle,  2011),  putting  survivors  at  CVD
risk.  Given  that  these  two  cancer  types  have  a  high  sur-
vival  rate,  and  a  signiﬁcant  proportion  of  these  individuals
have  comorbidities  resulting  in  increased  CVD  risk  (Loprinzi
&  Lee,  2014),  interventions  to  increase  physical  activity  in
these  patients  are  important.
Although  cancer  survivors  are  at  increased  CVD  risk  and
recurrence,  clinicians  may  be  optimally  positioned  to  cap-
italize  on  the  ‘teachable  moment’  (Demark-Wahnefried,
Azid,  Rowland,  &  Pinto,  2005)  or  post-traumatic  growth
(Ochoa,  Casellas-Grau,  Vives,  Font,  &  Borràs,  2017)  created
by  the  cancer  diagnosis  and  play  a  central  role  in  guiding
survivors  toward  positive  health  behaviours  that  improve
overall  health  and  physical  well-being.
Interventions  that  incorporate  behaviour  change  tech-
niques  including  goal-setting,  counselling  and  feedback  to
increase  physical  activity  and  improve  quality  of  life  in
survivors  have  yielded  promising  ﬁndings  (Bennett,  Lyons,
Winters-Stone,  Nail  &  Scherer,  2007;  De  la  Torre-Luque,
Gambara,  López,  &  Cruzado,  2016).  Based  on  the  effec-
tiveness  of  these  interventions  and  our  recent  qualitative
work  (Hardcastle,  Glassey,  Salﬁnger,  Tan  &  Cohen,  2017;
Hardcastle,  Maxwell-Smith,  et  al.,  2017;  Maxwell-Smith,
Zeps,  Hagger,  Platell  &  Hardcastle,  2017),  addressing  sup-
port  needs  and  facilitating  self-monitoring  strategies  for
survivors  are  important  components  of  successful  interven-
tions  (Hardcastle  et  al.,  2015).
Wearable trackers
Wearable  activity  technology  (WAT)  holds  great  potential
as  a  self-monitoring  tool  to  increase  physical  activity  in
survivors.  WAT  and  associated  ‘apps’  use  many  of  the  tech-
niques  employed  in  physical  activity  interventions  (i.e.,  self-
monitoring,  feedback,  goal-setting)  (Lyons,  Lewis,  Mayrsohn
y  Rowland,  2014).  Thus,  WAT  presents  a  feasible  opportu-
nity  for  widespread  physical  activity  promotion  (Sanders
et  al.,  2016).  Previous  physical  activity  interventions  for
cancer  survivors  have  used  pedometers  as  self-monitoring
tools  (Bennett  et  al.,  2007).  WAT  is  hypothesised  to  be  more
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effective  than  pedometers  for  increasing  physical  activity
because  it  provides  real-time  feedback  and  prompts,  links  to
mobile  applications  where  users  can  monitor  behaviour  and
create  a  network  to  promote  accountability,  and  facilitates
peer-support  amongst  other  users.
The  FitbitTM has  demonstrated  effectiveness  for  increas-
ing  physical  activity  in  overweight  and  obese  adults  (Wang
et  al.,  2015).  The  ﬁrst  FitbitTM trial  in  cancer  survivors  has
recently  been  published,  however  the  FitbitTM and  Facebook
intervention  targeted  adolescent  cancer  survivors  (Mendoza
et  al.,  2017).  To  our  knowledge,  no  study  has  assessed  the
effectiveness  of  the  FitbitTM to  increase  physical  activity  in
adult  survivors.
Health  Action  Process  Approach
Physical  activity  interventions  that  are  based  on  theoreti-
cal  underpinnings  have  been  more  successful  for  improving
health-related  outcomes  compared  to  those  without  theo-
retical  bases  (atheoretical)  (Bennett  et  al.,  2007;  Parschau
et  al.,  2014).  The  Health  Action  Process  Approach  (HAPA)
attempts  to  overcome  the  ‘intention-behaviour  gap’  by
proposing  two  phases  that  are  required  for  behaviour
change;  motivation  and  volition  (Schwarzer  &  Luszczynska,
2008).  Motivational  processes  involve  initial  recognition  of
risk  perception  and  positive  outcome  expectances  associ-
ated  with  behavioural  change.  The  individual  must  form  an
intention  to  change  and  graduate  to  volitional  processes  by
acting  on  this  intention.  This  requires  planning  and  self-
efﬁcacy  for  the  proposed  behaviour  and  self-regulation  to
monitor  and  maintain  the  behavioural  change  (Schwarzer
&  Luszczynska,  2008).  A  recent  intervention  by  Ungar,
Sieverding,  Weidner,  Ulrich,  and  Wiskemann  (2016)  found
survivors  who  received  HAPA-based  counselling  to  enhance
self-regulation  were  signiﬁcantly  more  active  than  a control
group.
Given  the  promise  of  the  HAPA  model  and  the  importance
of  self-regulation  for  successful  behaviour  change,  physical
activity  interventions  for  survivors  that  involve  monitoring
and  motivational  tools  are  warranted.  The  use  of  a  FitbitTM
as  a  motivational  device  to  increase  physical  activity  in  can-
cer  survivors  is  yet  to  be  explored  and  is  a  novel  aspect  of
the  study.
We  aim  to  determine  whether  a  pragmatic  interven-
tion  package  using  WAT,  coupled  with  action-planning,
goal-setting  and  coping  planning  is  effective  for  increas-
ing  physical  activity  and  reducing  sedentary  behaviour  in
gynecologic  and  colorectal  cancer  survivors  at  CVD  risk.  A
secondary  aim  is  to  assess  the  acceptability  of  this  interven-
tion  that  could  be  incorporated  into  routine  after-care  for
survivors.
Method
Design
The  two-arm  Randomised  Controlled  Trial  (RCT)  tests  the
efﬁcacy  of  a  self-monitoring  intervention  relative  to  an
information  only  control  group.  Participants  will  complete
data  collection  at  baseline  (T1),  after  the  12-week  interven-
tion  (T2)  and  at  24-week  follow-up  (T3).  Ethics  approval  was
obtained  from  the  St.  John  of  God  Hospital  Human  Research
Ethics  Committee  (#1102),  and  reciprocal  approval  from
Hollywood  Private  Hospital.  The  reporting  of  the  study  will
adhere  to  the  CONsolidated  Standards  Of  Reporting  Trials
(CONSORT)  and  Standard  Protocol  Items:  Recommendations
for  Interventional  Trials  (SPIRIT)  guidelines  for  RCTs  (Begg
et  al.,  1996;  Chan  et  al.,  2013).  The  study  ﬂow  chart  is
presented  in  Figure  1.
Participants
Participants  will  be  stage  1  and  2  colorectal  and  gyne-
cologic  cancer  survivors  aged  18-80,  who  have  ﬁnished
active  treatment  (surgery,  chemotherapy,  and/or  radiothe-
rapy)  in  the  previous  5  years,  and  are  completing  less  than
150-minutes  of  Moderate-Vigorous  intensity  Physical  Activ-
ity  (MVPA)  per  week  (Rock  et  al.,  2012).  Participants  must
have  comorbidities  resulting  in  increased  CVD  risk  identiﬁed
through  hospital  records  (i.e.,  on  blood  pressure  medication
or  have  blood  pressure  >150/90  mmHg,  BMI  >28,  hyper-
cholesterolemia  >5.2mmol/L)  or  an  American  Society  of
Anaesthesiologists  (ASA)  score  of  2  or  3,  in  the  absence  of
medical  records.* Participants  who  are  in  remission  at  the
time  of  recruitment,  English-reading  and  speaking,  live  in
the  Perth  Metropolitan  area,  and  have  no  surgery  planned
for  the  6  months  following  recruitment  will  be  eligible  to
participate.
Exclusion  criteria  include  those  who  (1)  are  meeting  the
physical  activity  guidelines  (Rock  et  al.,  2012);  (2)  have  a
current  diagnosis  of  a  severe  psychiatric  illness  or  cardiac
abnormalities  (those  with  minor  psychiatric  diagnoses  will
be  eligible  if  they  are  willing  and  able  to  participate  in  the
intervention);  (3)  severe  disabilities  including  arthritis;  (4)
have  ASA  scores  of  1  or  4;  (5)  already  enrolled  in  a  physical
activity  program/trial;  (6)  have  been  diagnosed  with  uterine
carcinosarcoma  (MMMT),  uterine  serous  carcinoma,  or  ovar-
ian  cancer,  as  these  cancer  types  are  associated  with  a  poor
prognosis.
Individuals  with  an  ASA  score  of  2  or  3  will  be  eligi-
ble  for  recruitment.  An  ASA  score  from  1-4  is  assigned  to
patients  upon  admission  to  hospital  for  a  surgical  procedure.
A  low  ASA  score  indicates  minimal  cardiovascular  risk,  and
a  higher  ASA  score  suggests  comorbidities  that  threaten  a
patient’s  life.  Participants  with  ASA  scores  of  2  or  3  have
comorbidities  putting  them  at  risk  of  CVD.  The  ASA  score  is
globally  recognised  as  an  indicator  of  physical  health  sta-
tus  of  patients  prior  to  undergoing  surgery  (Owens,  Felts  &
Spitznagel,  1978).
Participants  will  be  recruited  using  purposive  sampling
methods,  involving  screening  the  hospital  records  of  par-
ticipating  oncologists  (N=8),  to  collate  a  pool  of  eligible
survivors.  The  participating  oncologists  are  based  at  St  John
of  God  Subiaco  and  Murdoch  Hospitals,  Hollywood  Private
Hospital,  and  the  Women  Centre  in  West  Leederville,  West-
ern  Australia.  Eligible  individuals  (N=588)  will  be  mailed  an
∗ Some oncologists use ASA scores as a primary indication of car-
diovascular risk. Other oncologists collect data on blood pressure,
cholesterol and body mass index.
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Phon e scree ned for eligibility (n=xx)
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Baseline assessment and
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Failed to meet inclusion 
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• •
•
•
•
•
•
•
Receive Fitbit and
intervention g roup  sessions
(n=xx)   
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12-wee k assessment
Lost to follow up  (n=xx)
12-wee k assessment
Lost to follow up  (n=xx)
24-wee k assessment
Lost to follow up  (n= xx)
Follow-up
24-wee k assessment
Lost to follow up  (n=xx)
Analysed (n=xx)
Excluded from analysis
(n=xx) 
Analysed (n=xx)
Excluded from analysis
(n=xx) 
Figure  1  Flow  diagram  of  trial  design.
invitation  letter  and  information  sheet  from  their  treating
oncologist.
An  independent  statistician  will  generate  the  randomi-
sation  sequence  using  STATA  v14  with  a  1:1  allocation
using  blocks  of  4.  Following  recruitment,  participants  will
be  allocated  to  either  intervention  or  control  groups  by
the  statistician  using  the  next  consecutive  randomisation
code.  Participants  will  be  randomly  sorted  into  blocks,
with  random  assignment  to  group  within  each  block.  Upon
randomisation,  participants  will  be  evenly  split  between
treatment  (N=34)  and  control  groups  (N=34).  Assessors  (post-
baseline),  clinicians  and  data  analysts  will  be  blinded  to
group  allocation.
Statistical  power  and  sample  size
For  each  GLMM,  the  2-way  Group  x  Time  interaction  embod-
ies  the  treatment  effect.  According  to  G*Power,  for  the
primary  outcome  (MVPA),  28  participants  in  each  of  the
two  groups  provides  sufﬁcient  power  for  an  80%  chance
of  detecting  a  ‘small  to  moderate’  (f=.17)  group  x  time
interaction  at  an  alpha  level  of  .05.  A  meta-analysis  of  phys-
ical  activity  interventions  in  cancer  survivors  reported  a
weighted  mean  effect  size  of  0.38  (95  CI:  0.22-0.54)  for  the
difference  between  groups  on  physical  activity  outcomes.
We  anticipate  a  similar  effect  size  (i.e.,  0.40).  We  aim
to  recruit  68  participants,  ensuring  that  if  20%  are  lost  to
follow-up,  the  intervention  will  still  be  adequately  powered
at  80%  to  detect  a  meaningful  change.  A  dropout  rate  of  20%
is  a  conservative  estimation,  given  previous  dropout  rates  of
∼10%  in  similar  intervention  designs  for  survivors  (Bennett
et  al.,  2007;  Short,  James,  Girgis,  Mcelduff,  &  Plotnikoff,
2012).
Instruments
The  primary  outcome  will  be  minutes  of  MVPA  and  sedentary
behaviour  ascertained  from  the  Actigraph  GT9X  (Actigraph,
LLC,  Pensacola,  Florida,  USA).  Participants  will  wear  the
accelerometer  on  their  right  hip  for  all  waking  hours  across  7
consecutive  days.  Individual  days  of  wear  time  must  exceed
10  hours  to  be  considered  valid  for  analysis.  Non-wear
periods  will  be  deﬁned  as  intervals  of  at  least  60  consecu-
tive  minutes  of  zero  counts  will  be  excluded  from  analyses.
Activity  counts  will  be  categorised  as:  sedentary  (<100cpm),
light-intensity  (100-1951cpm),  moderate-intensity  (1952-
5724cpm)  and  vigorous-intensity  (>5725cpm),  using  data
recorded  in  60-s  epochs  (Lynch  et  al.,  2016).
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Sedentary  behaviour  will  be  deﬁned  by  accelerom-
eter  activity  counts  of  <100cpm,  for  20  consecutive
minutes  or  more,  which  corresponds  to  clinical  changes
in  cardio-metabolic  biomarkers  (Lynch  et  al.,  2016).
The  accelerometer  log  completed  by  participants  will
assist  in  differentiating  sedentary  time  from  non-wear
time.
The  International  Physical  Activity  Questionnaire,  Short-
Form  (Craig  et  al.,  2003)  will  assess  self-reported  physical
activity  at  T1,  T2,  and  T3.  This  questionnaire  is  scored  based
on  the  amount  and  intensity  of  accumulated  minutes  of  exer-
cise  in  the  previous  week,  with  activity  being  converted  into
MET  minutes  as  a  function  of  intensity.  This  tool  is  reliable
(Cronbach’s  alpha  of  .80)  and  had  demonstrated  adequate
validity  across  12  countries  (Craig  et  al.,  2003;  Mama  et  al.,
2015).
Quality  of  life  will  be  measured  using  the  Medical  Out-
comes  Study  Short-Form  survey  (Ware,  Kosinski  &  Keller,
1996).  This  instrument  is  considered  reliable  across  both
mental  and  physical  components  (Cronbach’s  alpha  of  .87
and  .84,  respectively),  and  valid  when  compared  to  the  36-
item  version  (Dritsaki,  Petrou,  Williams,  &  Lamb,  2017;  Ware
et  al.,  1996).
Physical  activity  attitudes  will  be  measured  using  previ-
ously  published,  validated  items  from  the  HAPA  inventory,
with  Cronbach’s  alpha  scores  for  the  subscales  below  ran-
ging  from  .73  to  .87  (Parschau  et  al.,  2014).  Some  items
have  been  amended,  based  on  the  speciﬁc  barriers  identi-
ﬁed  by  survivors  (Bennett  et  al.,  2007;  Hardcastle,  Glassey
et  al.,  2017;  Maxwell-Smith  et  al.,  2017;  Short  et  al.,  2012),
and  physical  activity  guidelines  for  survivors  (Rock  et  al.,
2012).  The  following  constructs  will  be  assessed:
Outcome  expectations.  Twelve  items  will  assess  outcome
expectations.  Five  items  are  derived  from  the  validated
exercise  pros  subscale  (Plotnikoff,  Blanchard,  Hotz  &
Rhodes,  2001)  and  7-items  are  tailored  based  on  formative
research  with  cancer  survivors  (Bennett  et  al.,  2007; Hard-
castle,  Maxwell-Smith  et  al.,  2017;  Short  et  al.,  2012).  The
items  measure  the  extent  to  which  participants  agree  or  dis-
agree  (1=disagree  very  strongly  to  6=agree  very  strongly)
that  regular  physical  activity  over  the  next  12-weeks  will
help  to:  reduce  tension  or  stress;  feel  more  conﬁdent  about
my  own  health;  sleep  better;  have  a  positive  outlook;
control  my  weight;  regain  lost  strength;  prevent  cancer
recurrence;  increase  fatigue;  increase  joint  pain;  weaken
my  immune  system;  feel  better  about  my  body,  and  increase
my  longevity.  For  example,  ‘Doing  regular  physical  activity
over  the  next  12-weeks  will  help  me  to  reduce  tension  or
stress’.
Action  self-efﬁcacy.  Four  items  will  assess  action  self-
efﬁcacy,  based  on  previous  research  with  breast  cancer
survivors  (Rogers  et  al.,  2005).  Items  assess  participants’
conﬁdence  to  complete  150-minutes  of  physical  activity
per  week,  with  the  item  stems:  ‘I  believe  I  have  the  abil-
ity  to.  .  .’; ‘I  am  conﬁdent  I  can  do.  .  .’; ‘If  I  wanted  to  I
could.  .  .’ and  ‘For  me  to  do.  .  .’, For  example,  ‘I  am  conﬁ-
dent  I  can  do  150-minutes  of  moderate-intensity  physical
activity  per  week  for  the  next  12-weeks’.  Possible  responses
range  from  1=extremely  difﬁcult,  disagree  very  strongly,
extremely  unconﬁdent  to  6=extremely  easy,  agree  very
strongly,  extremely  conﬁdent.
Maintenance  self-efﬁcacy.  Thirteen  items  will  assess
maintenance  self-efﬁcacy,  with  based  on  formative  research
(Hardcastle,  Maxwell-Smith  et  al.,  2017;  Short  et  al.,  2012).
Items  measure  conﬁdence  to  participate  in  regular  physi-
cal  activity  over  the  next  12-weeks  when:  I lack  discipline;
exercise  is  not  a  priority;  the  weather  is  bad;  I am  feel-
ing  tired;  I  lack  time;  I do  not  enjoy  exercising;  I  do  not
have  someone  to  encourage  me  to  exercise;  I  am  in  a
bad  mood  or  feeling  depressed;  I  have  to  exercise  alone;
I  can’t  notice  any  improvements  in  physical  ﬁtness;  I  feel
stiff  or  sore;  I  feel  unwell,  and  I can’t  notice  any  improve-
ments  in  my  body.  Responses  are  scored  on  a  six-point
Likert  scale  from  1=disagree  very  strongly  to  6=agree  very
strongly.
Action  planning.  Four  items  will  assess  action  planning
for  the  next  3-weeks,  based  on  an  amended  scale  (Rhodes,
Blanchard,  Matheson,  &  Coble,  2006).  Participants  will  be
asked  to  respond  on  a  scale  of  1=disagree  very  strongly  to
6=agree  very  strongly  about  whether  they  have  made  plan
concerning  what, when, where, and  how  they  will  engage
in  regular  physical  activity.
Risk  perception.  Four  items  will  measure  risk  perception,
based  on  a  previous  scale  (Graham,  Prapavessis,  &  Cameron,
2006).  Items  are  scored  on  a  six-point  Likert  scale  from
1=disagree  very  strongly,  extremely  unlikely,  very  much
lower,  to  6=agree  very  strongly,  extremely  likely,  very  much
higher.  Items  measure  ‘perceived  risk. .  .’, ‘vulnerability. .  .’,
‘likelihood. .  .’ and  ‘chance.  .  .of  developing  health  problems
related  to  an  inactive  lifestyle,  compared  to  the  average
person’.
Intention.  Two  items  will  measure  intention  to  engage  in
moderate-intensity  physical  activity  for  at  least  150-minutes
per  week  in  the  next  12-weeks,  based  on  previously  estab-
lished  measures  (Ajzen,  Brown  &  Carvajal,  2004).  Items  are
‘I  intend. . .’ and  ‘I  will  try.  . .to  participate  in  moderate-
intensity  physical  activity  for  at  least  150-minutes  per  week
in  the  next  12-weeks’.  Items  will  be  scored  on  a  six-point
Likert  scale  from  1=disagree  very  strongly  to  6=agree  very
strongly.
Several  demographic  characteristics  and  comorbidities
have  been  identiﬁed  as  covariates  in  cancer  survivors,  based
on  similar  research  (Loprinzi  &  Lee,  2014).  Therefore,  we
will  obtain  this  information  at  T1  including  marital  status,
household  income  and  educational  attainment.  Cardiovas-
cular  risk  will  be  measured  at  each  assessment  using  the
QRISK2,  which  has  been  validated  in  the  UK  and  is  used  inter-
nationally  (Collins  &  Altman,  2010).  The  QRISK2  data  will  be
entered  into  the  online  algorithm  (www.qrisk.org),  where
scores  will  be  calculated.
Blood  pressure  will  be  measured  using  an  Omron  IC-10
Upper  Arm  Blood  Pressure  Monitor  (HEM  7070-E),  which  has
been  validated  for  use  by  the  British  Hypertension  Society
(British  Hypertension  Society,  2017).  BMI  will  be  calculated
by  measuring  height  and  weight.
Intervention  acceptability  will  be  assessed  at  T3,  where
participants  will  be  invited  to  provide  feedback  concern-
ing  the  effective  and  ineffective  components  and  the
practicality  of  the  intervention  via  interviews.  FitbitTM
use  will  be  monitored  weekly  using  the  FitbitTM soft-
ware,  to  assist  with  the  assessment  of  intervention
adherence.
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Procedure
Participants  will  contact  a  member  of  the  trial  team  to
express  their  interest  in  participating  in  the  study.  Those
who  express  interest  will  undergo  phone  screening  to
assess  eligibility,  before  organising  their  baseline  assessment
appointment.
Assessments  will  be  conducted  in  a  clinic  room  at  St.
John  of  God  Subiaco  Hospital,  Perth,  Australia.  The  base-
line  assessments  will  be  performed  by  a  member  of  the
trial  team,  prior  to  randomisation.  Subsequent  assessments
will  be  performed  by  a  trial  co-ordinator  who  is  blinded  to
group  allocation  and  not  involved  in  the  administration  of
the  intervention.  Group  sessions  will  be  held  in  a meet-
ing  room  at  St.  John  of  God  Subiaco  Hospital  and  led  by
team  investigators.  Text  messages  and  phone  calls  will  act  as
reminders  for  participants  to  attend  group  sessions.  Atten-
dance  at  group  sessions  will  be  monitored  as  a  measure  of
intervention  adherence.
The  baseline  assessment  will  begin  with  participants
reading  the  information  sheet  before  providing  consent  to
participate.  Participants  will  be  required  to  complete  a
demographic,  physical  activity,  quality  of  life,  exercise  atti-
tudes,  and  cardiovascular  risk  questionnaire.  Height  (at  T1),
weight,  and  blood  pressure  will  then  be  recorded  by  the
assessor.  At  the  end  of  their  assessment,  participants  will  be
provided  with  an  Actigraph  GT9X  accelerometer  to  record
their  activity  for  the  subsequent  week,  an  accelerometer
log  for  recording  accelerometer  wear,  and  a  booklet.  The
assessor  will  inform  the  participant  of  the  accelerometer
wear  instructions  and  provide  a  prepaid  postage  satchel  for
accelerometer  return.  The  assessment  procedure  will  be
repeated  at  T2  and  T3.  The  intervention  will  cease  prior  to
the  T2  assessment  and  the  treatment  group  will  be  required
to  return  their  FitbitTM at  T3.
The  intervention  includes  three  components:  (1)  a  Fitbit
AltaTM;  (2)  two  group  sessions;  (3)  one  telephone-delivered
feedback  and  support  session.  All  participants  will  receive  a
printed  booklet  on  physical  activity  guidelines,  home-based
strength  exercises,  beneﬁts  of  regular  physical  activity,
physical  activity  logs,  conﬁdence  building,  barrier  solving,
coping  planning,  action-planning  and  goal-setting  activities.
Intervention  group
I.  WAT  tracker:  Participants  are  provided  with  a  Fitbit
AltaTM activity  tracker,  which  they  will  sign-out  at  their
ﬁrst  group  sessions,  and  be  encouraged  to  wear  for  the
duration  of  the  trial.  This  is  a  slim,  wrist-worn  device
that  displays  steps,  distance,  active  minutes  (MVPA)  and
caloric  expenditure.  The  FitbitTM was  chosen  because
previous  work  demonstrates  its  usefulness  and  accep-
tance  amongst  cancer  survivors  (Nguyen  et  al.,  2017)
and  older  adults  (>70;  McMahon  et  al.,  2016).  The
Fitbit  AltaTM also  alerts  users  to  sedentary  behaviour
and  progress  towards  activity  goals.  Data  from  the
device  can  be  uploaded  to  the  FitbitTM application  via
Bluetooth.  At  the  ﬁrst  group  session  participants  will
be  assisted  to  install  the  smartphone/tablet/computer
application,  and  to  pair  their  device  with  the  appli-
cation.  A  member  of  the  trial  team  will  send  friend
requests  to  each  participant  so  that  engagement  with
the  application  and  activity  can  be  monitored  weekly.
II.  Group  sessions:  Sessions  lasting  for  approximately  2-
hours  will  be  delivered  at  weeks  1  and  4,  with
approximately  10-12  participants  in  each  session.  Group
sessions  will  correspond  with  components  of  the  HAPA-
model.
a.  Session  one  will  focus  on  introducing  participants  to
the  Fitbit  AltaTM and  giving  instructions  on  how  to  use
the  device  as  a  self-monitoring  tool.  The  ﬁrst  part
of  the  session  will  be  largely  didactic  covering  risks
of  inactivity  (corresponding  to  the  ‘risk  perceptions’
construct  in  HAPA),  the  beneﬁts  of  physical  activ-
ity  (targeting  positive  ‘outcome  expectancies’  of  the
HAPA),  detailed  physical  activity  guidelines  (steps
and  MVPA)  and  enhancing  conﬁdence  and  importance
to  participate  in  physical  activity  at  the  recom-
mended  level  (targeting  ‘action  self-efﬁcacy’  and
‘intention’).  In  keeping  with  this  approach,  perso-
nalised  physical  activity  feedback  will  be  provided
to  each  participant  based  on  their  T1  accelerometer
data.  During  this  session,  participants  will  be  encour-
aged  to  complete  action-planning  (corresponding  to
HAPA  ‘action-planning’  as  a  strategy  to  aid  the  trans-
lation  of  intentions  to  behaviour),  and  goal-setting
exercises  from  the  intervention  booklet  for  the  fol-
lowing  3-weeks.  Behaviour  change  specialist  SH  and
CMS  will  assist  participants  with  action-planning,
goal-setting  and  self-monitoring  activities.
b.  Session  two  (week  4)  will  attend  to  support  needs,
problem  solving  and  coping  planning.  The  session
will  use  the  intervention  booklet  to  prompt  physical
activity  planning  and  coping  planning  (correspond-
ing  to  HAPA  ‘coping  planning’)  for  the  following
four  weeks,  as  well  as  targeting  maintenance  self-
efﬁcacy.  Speciﬁcally,  participants  will  be  asked  to
consider  situations  or  obstacles  to  implementing
their  physical  activity  plans,  and  form  ‘if-then
plans’.  The  ﬁnal  part  of  the  session  will  involve
demonstrations  of  strength-training  exercises  that
could  be  performed  at  home,  using  household  items.
Participants  will  be  given  the  opportunity  to  practice
strength-based  exercises  during  the  session  to  check
technique  and  foster  perceptions  of  conﬁdence.  This
session  will  also  allow  for  trouble-shooting  of  prob-
lems  that  participants  encounter  regarding  FitbitTM
use.
III.  Telephone-delivered  feedback  and  support  session:  A
trial  team  member  will  telephone  each  participant  dur-
ing  week  8  of  the  trial  for  approximately  20-minutes.
The  purpose  of  the  call  will  be  to  discuss  progress
to  date,  with  a  focus  on  self-regulation,  maintenance
self-efﬁcacy  and  coping  planning  based  on  the  prin-
ciples  of  the  HAPA  and  the  relational  techniques  of
motivational  interviewing  (Hardcastle,  Fortier,  Blake,  &
Hagger,  2017).  Coping  planning  to  overcome  barriers  will
also  be  discussed.
Control  group.  Participants  in  the  control  group  will
receive  the  intervention  booklet  containing  physical  activ-
ity  guidelines  and  motivational  tools.  However,  the  control
group  will  not  receive  group  sessions,  a  Fitbit  AltaTM or
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a  telephone-delivered  support  session.  Participants  will
receive  feedback  on  their  physical  activity  levels  and  be
offered  the  opportunity  to  trial  the  Fitbit  AltaTM for  6-weeks
following  trial  completion  (after  T3).
Statistical  analysis
Primary  and  secondary  outcome  variables  will  be  analysed
via  a  series  of  Generalised  Linear  Mixed  Models  (GLMMs)
employing  appropriate  distributions  and  link  functions  for
each  outcome  measure.  All  GLMMs  will  include  the  ﬁxed
effects  Group  (Intervention  v  Control),  Time  (T1,  T2  and  T3)
and  the  2-way  interaction.  A  random  effect  for  participant
will  be  included  to  account  for  the  correlation  within  people
inherent  in  a  longitudinal  design.
Cancer  type,  gender,  age,  socio-economic  status,  BMI,
and  blood  pressure  will  be  included  as  covariates  within  the
model.  Compared  to  the  traditional  statistical  procedures
for  analysing  behavioural  change,  GLMM  is  less  sensitive  to
participant  attrition  because  it  does  not  rely  on  participants
providing  data  at  every  assessment  point;  the  GLMM  maxi-
mum  likelihood  procedure  is  a  full  information  estimation
procedure  that  uses  all  data  present  at  each  assessment
time-point.  Missing  data  will  be  investigated  for  patterns
in  terms  of  observed  study  variables.  Multiple  imputation
will  be  considered  if  data  are  arguably  missing  at  random
and  less  than  20%  of  the  data  are  missing.  We  will  impute  25
data  sets  based  on  all  relevant  observed  variables,  includ-
ing  the  interaction  term  and  outcome  measure  of  interest  for
each  speciﬁc  analysis.  Sensitivity  analyses  will  be  conducted
to  consider  the  effect  of  potential  missing  not  at  random
mechanisms  on  parameter  estimates  from  imputed  datasets
(Sterne  et  al.,  2009).  Qualitative  data  from  post-trial  inter-
views  will  be  analysed  using  inductive  thematic  analysis  to
identify  common  themes  concerning  active  ingredients,  bar-
riers  to  behaviour  change  and  acceptability  (Braun  &  Clarke,
2006).
Discussion
The  trail  will  examine  the  effectiveness  and  acceptability
of  an  intervention  that  combines  WAT  (The  Fitbit  Alta)  with
self-regulation  techniques  (action-planning,  goal-setting,
and  coping  planning)  to  increase  physical  activity  and  reduce
sedentary  behaviour  in  colorectal  and  gynecologic  cancer
survivors.  This  protocol  describes  the  ﬁrst  intervention  to
employ  the  Fitbit  AltaTM to  promote  physical  activity  in
adult  survivors,  contributing  to  the  growing  research  on  the
effectiveness  of  home-based,  brief  interventions  to  promote
physical  activity.
There  is  growing  evidence  to  suggest  that  physical  activ-
ity  reduces  risk  of  CVD  and  cancer  recurrence  (Hamer  &
Warner,  2017).  However,  few  survivors  are  meeting  the  mini-
mum  physical  activity  guidelines  (Rock  et  al.,  2012).  Physical
activity  interventions  that  meet  the  preferences  and  sup-
port  needs  of  cancer  survivors,  are  feasible,  and  can  be
integrated  into  routine  practice  are  needed  (Hardcastle  &
Cohen,  2017).
Previous  research  supports  the  exercise  preferences  of
cancer  survivors  for  home-based,  unsupervised,  self-paced,
low-moderate  intensity  physical  activity  that  involves
primarily  walking  (Hardcastle  &  Cohen,  2017;  Hardcastle  et
al.,  2018;  Maxwell-Smith  et  al.,  2017),  and  the  desire  for
monitoring  and  accountability  (Bennett  et  al.,  2007;  Hard-
castle,  Maxwell-Smith  et  al.,  2017).  Since  self-monitoring
(Hardcastle  et  al.,  2015) has  been  identiﬁed  as  effective
strategies  for  increasing  physical  activity,  WAT  may  serve
as  a  valuable  tool  for  measuring  activity  in  a  practical  and
motivational  way.  Further,  home-based  interventions  offer
advantages  because  they  mitigate  access  and  transport
issues,  and  are  less  expensive  than  supervised,  facility-
based  programs  that  require  participants  to  attend  classes
or  maintain  a  health  club  membership  (Hardcastle,  Glassey
et  al.,  2017).  Examination  of  intervention  acceptability  will
indicate  whether  such  programs  can  be  implemented  for
improving  physical  activity  of  cancer  survivors  as  part  of
follow-up  care.
Between  12-weeks  (T2)  and  24-weeks  (T3),  interven-
tion  participants  will  keep  the  activity  tracker  but  receive
no  formal  support.  Therefore,  changes  in  physical  activity
between  T2  and  T3  in  the  intervention  group  will  provide
some  insight  concerning  whether  ongoing  behavioural  sup-
port  is  necessary  in  combination  with  WAT  to  sustain
increases  in  MVPA  and  reductions  in  sedentary  behaviour.
Interventions  that  are  able  to  demonstrate  sustained
increases  in  physical  activity  are  needed.
Conclusion
The  trial  is  pragmatic  and  primarily  concerned  with  eval-
uating  whether  a  low-intensity  intervention  package  (WAT
combined  with  limited  behavioural  support)  is  effective  for
increasing  MVPA  and  reducing  sedentary  behaviour  in  sur-
vivors  compared  to  usual  care.  If  found  to  be  effective,
the  low-cost  intervention  could  be  integrated  into  clinical
practice  and  delivered  by  oncology  clinicians/nurses,  allied
professionals  or  charitable  organisations.
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